{"SPADE_UN_19017": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_19017", "Peptide Name": "KDEON WK-11 (Synthetic AMPs, Trp-rich, Lys-rich, UCLL1; BBMm)", "Source": "de novo designed", "Family": "Not found", "Gene": "Not found", "Sequence": "WWKKWWKKWWK", "Sequence Length": 11, "UniProt Entry": "Ref", "Protein Existence": "Not found", "Biological Activity": ["Anti-Gram+", "Anti-Gram-", "Antifungal", "Antifungal"], "Target Organism": "Not found", "Hemolytic Activity": "Not found", "Cytotoxicity": "Not found", "Binding Target": "Not found", "Linear/Cyclic": "Not found", "N-terminal Modification": "Not found", "C-terminal Modification": "Not found", "Stereochemistry": "Not found", "Structure Description": "Not found", "Formula": "Not found", "Mass": 1776.14, "PI": 10.6, "Hydrophobicity": -2.26, "Half Life": "Not found", "Function": "Not found", "Literature": [{"Author": "Casciaro B, Loffredo MR, Cappiello F, O'Sullivan N, Tortora C, Manzer R, Karmakar S, Haskell A, Hasan SK, Mangoni ML.2022", "Reference": "Front Chem. 2022 Nov 17;10:1000765. doi: 10.3389/fchem.2022.1000765.PubMed", "Title": "KDEON WK-11: A short antipseudomonal peptide with promising potential."}], "Frequent Amino Acids": "WK", "Absent Amino Acids": "ACDEFGHILMNOPQRSTUVY", "Basic Residues": 5, "Acidic Residues": 0, "Hydrophobic Residues": 6, "Polar Residues": 5, "Positive Residues": 5, "Negative Residues": 0, "Net Charge": 5, "Comments": "Sequence analysis: APD analysis reveals that this sequence is similar (63.64%) toHHC-48W: 55%; K: 45%. GRAVY: -2.26, mol Wt: 1776.143; mol formula: C96H128N22O12; mol ex coeff: 33300.Activity: active against Gram+ S. aureus ATCC 25923A (MIC 25 uM), S. epidermidis ATCC 12228 (MIC 3.12 uM), B. megaterium Bm 11 (MIC 0.75 uM), Gram- bacteria A. baumannii ATCC 19606 (MIC 50 uM), , P. aeruginosa (MIC 3.12 uM), E. coli ATCC 25922 (MIC 6.25 uM), P. aeruginosa ATCC 27853 or 19595 or 4 clinical strains (MIC 1.56-6.12 uM), and yeast C. albicans ATCC 24433 (MIC 6.25 uM). Bactericidal effect. It inhibited biofilm formation:P. aeruginosa as gauged by biomass (CV) and metabolic activity.MOA:bacteria:S. epidermidis: MOA:bacteria:P. aeruginosa:  MOA:fungi:C. albicans: the peptide showed membrane permeabilizaiton.Resistance development:no:bacteria:P. aeruginosa 19595:  the clinical isolate P. aeruginosa 19595 did not develop clear resistance to the peptide (MIC change 2 fold) or colistin (MIC change up to 4 fold) after 15 passages.In vitro toxicity: showed minimal toxicity to HaCaT cells (20% viability decrease at 25 uM and 25% decrease at 50 uM).", "Similar Sequences": [{"SPADE_ID": "SPADE_N_06474", "Similarity": 1.0, "Sequence": "NGVQPKYKWWKWWKKWW"}, {"SPADE_ID": "SPADE_N_09942", "Similarity": 1.0, "Sequence": "KWWKVKVK"}, {"SPADE_ID": "SPADE_N_09943", "Similarity": 1.0, "Sequence": "KWWKWKVK"}]}}}